Inhibition of receptor binding stabilizes Newcastle disease virus HN and F protein-containing complexes by McGinnes, Lori & Morrison, Trudy G.
University of Massachusetts Medical School 
eScholarship@UMMS 
Open Access Articles Open Access Publications by UMMS Authors 
2006-02-28 
Inhibition of receptor binding stabilizes Newcastle disease virus 
HN and F protein-containing complexes 
Lori McGinnes 
University of Massachusetts Medical School 
Et al. 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/oapubs 
 Part of the Life Sciences Commons, and the Medicine and Health Sciences Commons 
Repository Citation 
McGinnes L, Morrison TG. (2006). Inhibition of receptor binding stabilizes Newcastle disease virus HN 
and F protein-containing complexes. Open Access Articles. https://doi.org/10.1128/
JVI.80.6.2894-2903.2006. Retrieved from https://escholarship.umassmed.edu/oapubs/1515 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Open Access Articles 
by an authorized administrator of eScholarship@UMMS. For more information, please contact 
Lisa.Palmer@umassmed.edu. 
JOURNAL OF VIROLOGY, Mar. 2006, p. 2894–2903 Vol. 80, No. 6
0022-538X/06/$08.000 doi:10.1128/JVI.80.6.2894–2903.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
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Receptor binding of paramyxovirus attachment proteins and the interactions between attachment and fusion
(F) proteins are thought to be central to activation of the F protein activity; however, mechanisms involved are
unclear. To explore the relationships between Newcastle disease virus (NDV) HN and F protein interactions
and HN protein attachment to sialic acid receptors, HN and F protein-containing complexes were detected and
quantified by reciprocal coimmunoprecipitation from extracts of transfected avian cells. To inhibit HN protein
receptor binding, cells transfected with HN and F protein cDNAs were incubated with neuraminidase from the
start of transfection. Under these conditions, no fusion was observed, but amounts of HN and F protein
complexes increased twofold over amounts detected in extracts of untreated cells. Stimulation of attachment
by incubation of untransfected target cells with neuraminidase-treated HN and F protein-expressing cells
resulted in a twofold decrease in amounts of HN and F protein complexes. In contrast, high levels of complexes
containing HN protein and an uncleaved F protein (F-K115Q) were detected, and those levels were unaffected
by neuraminidase treatment of cell monolayers or by incubation with target cells. These results suggest that
HN and F proteins reside in a complex in the absence of receptor binding. Furthermore, the results show that
not only receptor binding but also F protein cleavage are necessary for disassociation of the HN and F
protein-containing complexes.
Paramyxoviruses, such as Newcastle disease virus (NDV),
initiate infection by the combined action of the two viral glyco-
proteins, the hemagglutinin-neuraminidase (HN) protein and
the fusion (F) protein. The HN protein, the virus attachment
protein, binds to sialic acid-containing receptors, and the F
protein directs the fusion of the virus membrane with the cell
membrane (reviewed in reference 15). Paramyxovirus F pro-
teins do not require the acid pH of endosomes to activate
fusion activity (7, 15). Because of this acid-independent fusion,
cells expressing the HN and F proteins can fuse with adjacent
cells to form multinuclear cells or syncytia in a process that is
often assumed to mimic virus-cell fusion (7, 15).
Viral fusion proteins have been classified into two groups
based on their structure and mechanisms for mediating fusion
(9, 17). Class 1 fusion proteins, which are trimers, include
paramyxovirus F proteins as well as the influenza hemaggluti-
nin protein and retrovirus env proteins (7). These fusion pro-
teins are synthesized as an inactive precursor, and proteolytic
cleavage generates two subunits, F1 and F2, in the case of
paramyxoviruses (7, 15). The new amino terminus, generated
by cleavage of the precursor, is the fusion peptide (FP). Class
1 fusion proteins also contain two important heptad repeat
(HR) domains (reviewed in reference 3). The F protein HR
domains are located just carboxyl terminal to the fusion pep-
tide (HR1 or HRA) and adjacent to the transmembrane (TM)
domain (HR2 or HRB). HR1 and HR2 peptides have a strong
affinity, forming a very stable, six-stranded, coil-coil, with the
HR1 forming an interior trimer and the HR2 binding in the
grooves of the trimer in an antiparallel orientation (1, 20, 51).
Based on the inhibitory effect of HR1 and HR2 peptides on
virus fusion (13, 16, 37, 38, 46, 48, 49), it is thought that the
HR1 and HR2 domains are not associated prior to F protein
activation while the two domains are complexed in the post-
fusion F protein (1, 38).
Current models for F protein-directed fusion propose that
the F protein, prior to the onset of fusion, is in a metastable
conformation and that activation of fusion induces conforma-
tional changes in the F protein (1, 3, 38). These changes are
proposed to expose the fusion peptide for insertion into a
target membrane, anchoring the F protein in that membrane
(1, 3, 45). The protein is thought to refold, forming the very
stable HR1-HR2 complex, a change that pulls the target and
the effector membranes together (1, 3, 45). Fusion of the two
membranes then proceeds.
The structure of the intact, prefusion, cleaved, metastable
F protein as it sits in membranes is not clear (2, 47). Fur-
thermore, the mechanisms involved in the activation of para-
myxovirus F proteins are poorly understood. The activation
of acid pH-independent fusion proteins is usually linked to
receptor binding (reviewed in reference 7). In the case of
most paramyxovirus F proteins, it is clear that HN protein
receptor binding is essential for F protein activity (30–32,
36). However, HN protein provides more than a docking
function, since some mutations in the HN protein elimi-
nated its fusion promotion activity without affecting attach-
ment and neuraminidase activity (4, 8, 39, 40, 42). Further-
more, the requirement for paramyxovirus HN proteins in
fusion is virus specific (10), providing strong support for the
idea that there is a specific and necessary interaction be-
tween the two proteins required for fusion activation.
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How an HN-F protein interaction serves to activate the F
protein is unknown. One model proposes that attachment of
HN protein to sialic acid receptors stimulates an interaction of
HN protein with F protein, and that interaction leads to F
protein refolding into its postfusion conformation (3, 14, 15). A
second model proposes that HN and F proteins form a com-
plex prior to HN protein attachment and that HN protein has
a role in the maintenance of the metastable conformation of
the F protein. In this model, HN protein receptor binding
stimulates a conformational change in the HN protein, releas-
ing the F protein to refold into a more stable conformation,
mediating membrane fusion in the process (23, 42, 50). A
determination of which proposal is correct would be an impor-
tant step in clarifying the molecular mechanisms involved in F
protein activation. The first model predicts that an inhibition
of HN protein attachment would block any association of the
two proteins. The second model predicts that an inhibition of
attachment should increase amounts of HN-F protein com-
plexes in cells, while stimulation of attachment should result in
a disassociation of the complexes. To address this question, we
quantified HN-F protein complexes under conditions that in-
hibited HN protein attachment to sialic acid and conditions
that promoted HN protein attachment. We found that amounts
of HN-F protein complexes, detected by coimmunoprecipita-
tion, were maximal under conditions that inhibited HN protein
attachment, while stimulation of attachment and fusion re-
sulted in a significant drop in the amounts of these complexes.
Furthermore, we found that disassociation of the complex re-
quired not only HN protein attachment but also F protein
cleavage. Our results support the proposal that HN and F
proteins reside in a complex prior to attachment of HN protein
to its receptors, a complex that disassociates with attachment
and fusion.
MATERIALS AND METHODS
Cells. A spontaneously transformed fibroblast cell line derived from the East
Lansing strain (ELL-0) of chicken embryos (UMNSAH/DF-1) was obtained
from the American Type Culture Collection and maintained in Dulbecco’s mod-
ified Eagle medium (DMEM) supplemented with penicillin-streptomycin and
10% fetal calf serum (FCS).
Plasmids. NDV cDNA sequences encoding HN, F wild type (Fwt), and un-
cleaved F (F-K115Q) proteins were subcloned into the expression vector
pCAGGS (28, 33) to generate pCAGGS-HN, pCAGGS-Fwt, and pCAGGS-F-
K115Q, respectively. The F-K115Q protein cDNA contained a point mutation in
the cleavage site sequence at residue 115 (K115Q) which eliminated the furin
recognition site. Some experiments required the use of an F protein with the
sequence tag, FLAG, added to the carboxyl terminus of Fwt protein, Fwt-FLAG,
or the F-K115Q protein, F-K115Q-FLAG. The FLAG sequence, added by stan-
dard PCR protocols, did not interfere with surface expression of either protein,
and in the case of Fwt protein, the tag did not interfere with cleavage or fusion
activity of the protein (data not shown). Plasmids pTA and pB1-G were obtained
from Clontech.
Antibodies. Anti-Fu1a is a mouse monoclonal antibody specific for NDV F
protein and was obtained from M. Peeples (29). Anti-HR1, anti-HR2, and
anti-Ftail antibodies were raised against peptides with sequences from the NDV
F protein HR1, HR2, and cytoplasmic domains, respectively, and have been
previously described (23, 26). Anti-F2-96 antibody was raised against a peptide
corresponding to amino acids 96 to 116 of the NDV F protein. Anti-HN mono-
clonal antibodies, anti-1c, anti-2b, anti-3a, and anti14c, were obtained from R.
Iorio (11, 12). Anti-AS antibody was raised against a peptide with a sequence
from the NDV HN protein and has been previously described (21, 25, 41).
Anti-A antibody was raised against a peptide with the sequence corresponding to
amino acid 49 to amino acid 117 of the NDV HN protein. Anti-H antibody was
raised against a peptide corresponding to amino acid 515 to amino acid 571 of
the NDV HN protein. Anti-FLAG monoclonal antibody was obtained from
Sigma Corp.
Transfection. Transfections of ELL-0 cells were accomplished using Lipo-
fectamine (Invitrogen) as recommended by the manufacturer. For each trans-
fection, a mixture of DNA (0.5 g/35-mm plate) and 7 l of Lipofectamine in
OptiMEM media (Gibco/Invitrogen) was incubated at room temperature for 45
min and added to cells previously washed with OptiMEM. The cells were incu-
bated for 5 h, the Lipofectamine-DNA complexes were removed, and 2 ml of
supplemented DMEM was added. Cells were incubated overnight at 37°C.
Coimmunoprecipitation. Transfected cells were washed with ice-cold phos-
phate-buffered saline (PBS) and then lysed in TNE buffer (25 mM Tris-HCl, pH
7.4, 150 mM NaCl, 5 mM EDTA) containing 1% Triton X-100, 2.5 mg/ml
N-ethylmaleimide, and 2 mg/ml DNase. Lysates were incubated on ice for 30 min
and then sheared by passing through a 25-gauge needle five times and then
vigorously vortexed. Excess primary antibody was added, and extracts were
incubated on ice for at least 2 h. Saturating amounts of all antibodies (amounts
of antibodies that resulted in maximal precipitation) were determined in prelim-
inary experiments. Pansorbin cells, blocked overnight in TNE buffer containing
1% Triton X-100 and 5 mg/ml bovine serum albumin (BSA) and then prewashed
in TNE containing 1% Triton X-100 and 1 mg/ml bovine serum albumen, were
added in excess as determined in preliminary experiments, and incubation was
continued at 4°C with constant mixing for at least 2 h. Immune complexes were
collected by centrifugation (10,000 rpm for 30 s in a microcentrifuge) and washed
three times in ice-cold TNE containing 0.5% Triton X-100. The pelleted com-
plexes were resuspended in gel sample buffer.
Polyacrylamide gel electrophoresis and Western blot analysis. Total cell ex-
tracts or immunoprecipitates, diluted in gel sample buffer (125 mM Tris-HCl, pH
6.8, 2% sodium dodecyl sulfate, 10% glycerol) with or without 0.7 M -mercapto-
ethanol, were loaded onto 8% polyacrylamide gels. After electrophoresis, gels
were equilibrated in transfer buffer (25 mM Tris, pH 8.2, 192 mM glycine, 15%
methanol) and transferred to Immobilon-P (Millipore Corp.) membranes. The
membranes were blocked overnight at 4°C in PBS containing 0.5% Tween 20 and
10% nonfat milk, washed with PBS-Tween 20, and incubated for 1 h at room
temperature with primary antibody diluted to 1:1,000 in PBS-Tween 20. Mem-
branes were then washed, incubated for 1 h at room temperature with secondary
antibody and goat anti-rabbit immunoglobulin G coupled to horseradish perox-
idase (Amersham Biosciences) diluted to 1:40,000 in PBS-Tween 20, and then
washed extensively in PBS-Tween 20. Bound antibody was detected using the
ECL Western blotting detection reagent system (Amersham Biosciences). Quan-
tification of the signal was accomplished using a Fluor-S imager (Bio-Rad). That
the signal was proportional to the amount of protein in the blot was determined
in preliminary experiments. Quantification of the signal was accomplished in the
linear range of the film and the imager detection.
Fusion assay. Content mixing due to fusion was measured using modifications of
a protocol previously described (8, 22). Briefly, a plasmid encoding a tetracycline-
responsive transcriptional activator, tTA (Clontech), was cotransfected (1 g/
35-mm plate) with pCAGGS-HN (0.5 g/35-mm plate) and pCAGGS-F DNAs
(0.5 g/35-mm plate). A separate population of avian cells was transfected with a
plasmid encoding the -galactosidase protein under the control of the tetracycline-
responsive transcriptional activator pB1-G (Clontech) (1 g/35-mm plate). After
mixing the two cell populations, incubation was continued for 6 h. Cells were
washed two times in PBS and lysed (Promega reporter cell lysis buffer), and
extracts were assayed for -galactosidase activity (Promega protocols). Activity
due to any background fusion was measured after mixing avian cells transfected
with only pTA and cells transfected with pB1-G. Values obtained were sub-
tracted from values obtained with cells expressing wild-type HN and wild-type F
proteins. Background was minimal and was at least 10-fold less than activities
obtained using cells expressing HN and Fwt protein.
Surface biotinylation. Monolayers of cells were washed three times in PBS-CM
buffer (PBS with 0.1 mM CaCl2 and 1 mM MgCl2). PBS-CM buffer was added
to monolayers, which were then incubated on ice for 10 min. The buffer was
removed, PBS-CM containing 0.5 mg/ml sulfosuccinimidyl 2 (biotinamido)-ethyl-
1,3-dithiopropionate (Pierce) was added, and the monolayers were incubated on
ice for 30 min. The cross-linker was removed, and 2 ml of DMEM was added.
Monolayers were incubated on ice for 5 min, washed three times in PBS, and
lysed as described above. To precipitate biotinylated molecules in immunopre-
cipitates, the immunoprecipitates were resuspended in TNE containing 0.5%
Triton X-100 and then incubated with neutravidin-agarose (Pierce) that had
been blocked in TNE containing 0.5% Triton X-100 and 5 mg/ml BSA and then
washed in TNE containing 0.5% Triton X-100 and 1 mg/ml BSA. The mix was
incubated on ice overnight and washed three times with TNE buffer containing
0.5% Triton X-100, and the precipitate was resuspended in gel sample buffer.
VOL. 80, 2006 RECEPTOR BINDING AND HN AND F PROTEIN INTERACTIONS 2895
 at UNIV O
F M
ASS M







Detection of HN-F protein complexes in avian cells. To
explore directly the relationship between HN and F protein-
containing complexes and HN protein receptor binding, we
first characterized HN-F protein complexes in extracts derived
from transfected avian cells. While coimmunoprecipitation of
NDV HN protein and F protein expressed in transfected mam-
malian cells has been demonstrated (6, 18), it was important to
characterize these complexes in avian cell extracts since HN
and F protein coexpression in these cells results in dramatically
more fusion than in mammalian cells (unpublished observa-
tions). Proteins present in transfected cell extracts were pre-
cipitated with a mix of anti-HN protein-specific antibodies or
anti-F protein-specific antibodies. The F protein present in the
immunoprecipitates was detected by Western blot analysis us-
ing a rabbit anti-F protein peptide antibody, while the HN
protein in the immunoprecipitates was detected in a separate
Western blot using rabbit anti-HN protein-specific peptide an-
tibody.
Figure 1A and B show that complexes containing both HN
and F proteins could be detected by reciprocal coimmunopre-
cipitation from these avian cell extracts. F protein was precip-
itated with anti-HN protein monoclonal antibodies (Fig. 1A,
lane 4). The F protein detected with anti-HN protein antibody
FIG. 1. Characterization of HN and Fwt protein complexes in avian cell extracts. (A and B) Cells were cotransfected with HN protein and F
wild-type (Fwt) protein cDNAs (lanes 1 to 4), Fwt cDNA (lanes 5 to 8), or vector (lanes 9 to 12). Immune complexes were formed using antibodies
(Ab) indicated at the top of panel A (IP Ab). IP, immunoprecipitation. (A) F protein detected in the complexes by Western blot analysis using
anti-HR2 (IB-F). IB, immunoblot. (B) HN protein present in the complexes (detected using anti-AS) (IB HN). Anti-HNmAbs, a mix of anti-HN
protein monoclonal antibodies. T, total extracts, representing 50% of that used for immunoprecipitation. (C and D) Cells were cotransfected with
HN protein and Fwt-FLAG cDNAs. Immune complexes were formed with antibodies indicated at the top of panels C and D (IP Ab). Anti-Fmix,
a mixture of anti-HR1, anti-HR2, anti-F2-96, anti-Ftail, and anti-Fu1a. F protein present in the immunoprecipitates was detected using anti-FLAG
monoclonal antibody (IB F). HN protein present in the extracts was detected using anti-AS antibody (IB HN). (E and F) Surfaces of cells
cotransfected with HN and Fwt protein cDNAs were biotinylated, and then cells were lysed. Immune complexes formed with the antibodies
indicated at the top of panel E (IP Ab) were solubilized and then precipitated with neutravidin as described in Materials and Methods. The F
protein in the resulting precipitates was detected by Western blot analysis with anti-HR2 (IB F), while the HN protein was detected using anti-AS
(IB HN). All proteins were electrophoresed in the presence of reducing agent.
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was not due to nonspecific aggregation, since omission of pri-
mary antibody in the precipitation protocol eliminated detec-
tion of F protein (lane 2). Furthermore, F protein in extracts
derived from cells expressing only F protein was not precipi-
tated with anti-HN protein antibodies (lane 8). Similarly, HN
protein in these extracts was precipitated with an anti-F pro-
tein monoclonal antibody (Fig. 1B, lane 3) but not from ex-
tracts containing only HN protein (Fig. 1B, lane 7) and not
when primary antibody was omitted during the precipitation
protocol (Fig. 1B, lanes 2 and 6).
HN-F protein complexes contain primarily mature proteins.
It has been suggested that HN and F proteins may form na-
scent protein complexes (34, 43, 44), which could account for
detection of HN-F protein complexes. However, complexes
detected in protocols used here were composed primarily of
mature proteins, folded proteins recognized by conformation-
ally sensitive antibodies, and proteins that were posttransla-
tionally modified. The F protein precipitated with the anti-HN
protein monoclonal antibodies was primarily the cleaved form
of the protein, F1 (Fig. 1A). In addition, the anti-HN protein
monoclonal antibodies used for precipitation recognize only
mature, folded HN protein (24), suggesting that mature HN
protein was complexed with F protein. However, two ap-
proaches were taken to verify this conclusion. First, anti-AS
antibody, which recognizes only nascent HN protein (24, 25),
did not precipitate F protein (Fig. 1C, lane 5), though it did
precipitate significant amounts of HN protein (Fig. 1D, lane 6).
In contrast, two other anti-HN protein peptide antibodies
(anti-H and anti-A) did precipitate the F protein (Fig. 1C,
lanes 3 and 4). Anti-A precipitates both nascent and mature
protein, while anti-H precipitates only disulfide-linked HN
protein (unpublished observations).
Second, Fig. 1E and F show that HN-F protein complexes
included cell surface material. Surfaces of cells were biotiny-
lated, and after cell lysis, proteins were precipitated with anti-HN
protein or anti-F protein antibodies. The immune complexes
were then precipitated with neutravidin in order to isolate
only surface molecules. Clearly, F protein precipitated with
anti-HN protein antibody included surface-biotinylated F pro-
tein (Fig. 1E, lane 4), and HN protein precipitated with anti-F
protein antibodies included biotinylated HN protein (Fig. 1F,
lane 3).
Figure 1D also shows that a mix of anti-F protein antibodies
precipitated HN protein more efficiently than the anti-Fu1a
monoclonal antibody (compare Fig. 1B, lanes 3 and 4, with D,
lanes 2 and 3). Approximately 2.5 times more HN protein was
reproducibly precipitated with the anti-F protein antibody mix
than with the anti-Fu1a monoclonal antibody. In addition, under
certain conditions, anti-HN protein monoclonal antibodies pre-
cipitated more F protein than the anti-Fu1a antibody (data not
shown). Thus, the mix of F protein antibodies was used for
subsequent experiments, since the monoclonal antibody likely
does not detect all the HN and F protein complexes.
HN-Fwt protein complexes increase with attachment inhi-
bition. In order to determine the effect of attachment on the
levels of these HN-F protein-containing complexes, we incu-
bated HN-F protein-expressing cells under conditions that
minimized attachment. Neuraminidase removes the sialic acid
receptors on surfaces of cells, inhibiting attachment and, there-
fore, fusion of these cells to adjacent untransfected cells (30).
Indeed, cell-cell fusion normally seen in these monolayers (Fig.
2A) was completely inhibited by neuraminidase (Fig. 2B), in-
dicating the effectiveness of the digestion. After neuraminidase
digestion of cell monolayers, the amounts of HN protein pre-
cipitated with anti-F protein antibody mix were significantly
increased over amounts detected in extracts from untreated
cells (Fig. 2C, compare lanes 3 and 7, indicated by arrows).
Similarly, neuraminidase treatment significantly increased amounts
of F protein precipitated with anti-HN antibody (Fig. 2D, com-
pare lanes 4 and 8). These results are consistent with the idea that
HN and F protein-containing complexes form in the absence of
HN protein receptor binding.
FIG. 2. Neuraminidase treatment of transfected cells increases de-
tection of immune complexes. (A and B) Cells cotransfected with HN
and Fwt protein cDNAs were untreated (A) or incubated with neur-
aminidase (0.5 U/ml, overnight incubation) (B). (C and D) Cells shown
in panels A and B were lysed, and immune complexes were formed
using antibodies (Ab) indicated at the top of panel C (IP Ab). IP,
immunoprecipitation. The F protein in these complexes (electropho-
resed in the absence of reducing agent) was detected using anti-HR2
(IB F) (C), and the HN protein in the complexes (electrophoresed in
the presence of reducing agent) was detected using anti-AS (IB HN)
(D). IB, immunoblot. Anti-HNmAbs, a mixture of monoclonal anti-
bodies. Complexes derived from untreated cells (NA) are shown in
lanes 1 to 4. Complexes derived from neuraminidase-treated cells
(NA) are shown in lanes 5 to 8. T, total cell extract, which represents
25% (C, lane 1) or 50% (B, lane 5, and D, lanes 1 and 5) that were used
for immunoprecipitation. (D) Signals in lanes 3 and 7 are a combina-
tion of comigrating F protein and precipitating rabbit antibody.
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HN and F protein complexes decrease with attachment.
Detection of larger amounts of HN-F protein-containing com-
plexes in the absence of attachment suggested that attachment
may result in the disassociation of these complexes. To test this
idea, we asked if the levels of these complexes, detected in
extracts from neuraminidase-treated cells, could be reduced if
these cells were mixed with untreated target cells to stimulate
attachment. To monitor the effectiveness of neuraminidase
digestion in eliminating surface receptors on target cells as well
as HN and F protein-expressing cells (effector cells), fusion
between effector and target cells, which requires HN protein
attachment to the target cells, was quantitatively measured in
a -galactosidase reporter assay previously described (8, 22,
27). Figure 3A shows that while both untreated or neuramin-
idase-treated effector cells fused efficiently with untreated tar-
get cells, neuraminidase treatment of the target cells elimi-
nated fusion, as did neuraminidase treatment of both target
and HN-F protein-expressing cells.
Using these conditions, the HN-F protein complexes were
isolated from extracts derived from mixtures of neuraminidase-
treated effector cells and either untreated or neuraminidase
treated target cells. The HN protein present in complexes is
shown in Fig. 3B, and the F protein in the complexes is shown
in Fig. 3C. The amounts of HN protein detected with anti-F
protein antibody in the absence of attachment (lane 7) clearly
decreased when attachment occurred between effector and
target cells (lane 3). Similarly, the amounts of F protein de-
tected with anti-HN protein antibodies in the absence of at-
tachment (lane 8) decreased after attachment (lane 4).
Quantification of multiple experiments identical to those
shown in Fig. 2 and 3 is presented in Fig. 4. Precipitation using
extracts from cells not treated with neuraminidase and without
an overlay of target cells (category 1) resulted in approximately
37% of mature HN protein (Fig. 4A) (and 27% of total HN
protein; Fig. 4B) precipitated with anti-F protein antibody,
while neuraminidase treatment of transfected cells resulted in
approximately 80% of mature HN protein (43% of total HN
protein) precipitated with anti-F protein antibody (Fig. 4, cat-
egory 2). Mature HN protein is defined as the HN protein
precipitated with the mix of anti-HN protein monoclonal an-
tibodies (24). Total HN protein is that detected without prior
immunoprecipitation. Furthermore, to eliminate effects of varia-
tions in expression between plates, the amount of HN precip-
itated with anti-F protein antibody was always compared to the
amounts of HN protein in the same extract precipitated with
anti-HN protein antibody.
In contrast to results with HN protein, it was possible to
quantify F protein in complexes only relative to the total F
protein in each extract, because anti-F protein rabbit antibod-
ies used as precipitating antibody obscured the F protein (Fig.
2D, lanes 3 and 7, and Fig. 3C, lanes 3 and 7). Approximately
12% of the total F protein (that detected without immunopre-
cipitation) was precipitated with anti-HN protein antibody in
the absence of neuraminidase treatment, while prior neur-
aminidase treatment resulted in approximately 28% of the
total F protein precipitated with anti-HN protein antibody.
Quantification of results of multiple experiments using ex-
tracts prepared after the addition of overlay target cells is also
shown in Fig. 4. The percent of mature HN protein precipi-
tated with anti-F protein antibodies under conditions that in-
hibited attachment (category 5) was approximately 90% (44%
of total HN protein). Attachment of untreated target cells to
neuraminidase-treated HN and F protein-expressing cells re-
sulted in detection of approximately 35% of mature HN pro-
FIG. 3. HN protein receptor binding decreases amounts of HN and
F protein complexes. (A) The fusion activities of mixtures of HN and
F protein-expressing cells and target cells, either untreated or treated
with neuraminidase (indicated at the bottom of the panel), were quan-
tified using a -galactosidase reporter assay. Cells cotransfected with
HN and Fwt protein cDNAs as well as pTA were untreated or treated
with the indicated concentrations of neuraminidase overnight. Target
cells, transfected with pB1-G only, were untreated or incubated with
the indicated concentrations of neuraminidase for 1 h prior to addition
to HN and F protein-expressing cells. Fusion between the HN and F
protein-expressing cells and target cells, quantified by measuring the
-galactosidase in cell extracts, is shown as the percent of activity
detected in mixes of untreated cells. (B and C) Cells cotransfected with
HN and F protein cDNAs were incubated overnight in 0.5 mg neur-
aminidase (NA). Target cells were either untreated (NA) (lanes 1
to 4) or treated with neuraminidase (NA) for 1 h (lanes 5 to 8),
washed, and then added on top of the HN and F protein-expressing
cells, and the mix was incubated for 1 h at 37°C. Immune complexes
were formed with antibodies (Ab) indicated at the top of panel B
(IP Ab). IP, immunoprecipitation. The HN protein (electrophoresed
in the presence of reducing agent) in the complexes was detected using
anti-AS (IB HN), and the F protein (electrophoresed in the absence of
reducing agent) was detected using anti-HR2 (IB F). IB, immunoblot.
Anti-Fmix, a mixture of anti-HR1, anti-HR2, anti-F2-96, anti-Ftail,
and anti-Fu1a. Anti-HNmAbs, a mixture of monoclonal antibodies.
T, total cell extract, which represents 50% of the amount used for
immunoprecipitation. (C) Bands in lanes 3 and 7 are a combination of
comigrating F protein and precipitating rabbit antibody.
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tein in the HN-F protein complexes (20% total HN protein)
(category 4). A similar pattern of results was obtained for the
F protein (Fig. 4C) by quantifying F protein in complexes
relative to total F protein.
In addition, mixtures of untreated target and effector cells
resulted in very low levels of detection of HN-F protein-con-
taining complexes (Fig. 4A, B, and C, category 3).
F protein cleavage and HN-F protein complexes. To deter-
mine if F protein cleavage influenced the detection of HN-F
protein complexes, extracts were prepared from cells trans-
fected with HN protein cDNA and F-K115Q cDNA. F-K115Q
cDNA contains a mutation in the F protein cleavage site se-
quence and, therefore, results in the expression of an un-
cleaved F protein (19). Complexes of HN and F proteins in
these extracts were detected as described above for Fig. 1.
The anti-HN protein antibodies precipitated F-K115Q protein
(Fig. 5B, lane 7) and the anti-F protein antibody mix precipi-
tated HN protein (Fig. 5A, lane 6). The anti-Fu1a monoclonal
antibody also precipitated HN protein (Fig. 5A, lane 10). Fur-
thermore, the anti-AS antibody did not precipitate significant
amounts of F-K115Q protein (Fig. 5B, lane 12), indicating that
most of the detected F-K115Q protein was not in a complex
with immature HN protein.
The HN–F-K115Q complexes were characterized from ex-
tracts untreated and treated with neuraminidase as described
in Fig. 2. Furthermore, complexes were isolated from extracts
after incubation of the transfected cells with an overlay of
target cells, either untreated or treated with neuraminidase, as
described in Fig. 3. The results of a typical experiment are
shown in Fig. 6, and the quantification of the results of three
identical experiments is shown in Fig. 7.
First, the amount of HN and F-K115Q protein complex
detected in extracts derived from untreated cells was signifi-
cantly higher than the amount of HN and Fwt protein complex
(85% versus 37%, respectively, of mature HN protein was
precipitated with anti-F protein antibodies). Furthermore, the
amount of HN–F-K115Q protein complex was unchanged by
neuraminidase treatment of these cells. These results suggest
that attachment did not decrease the amounts of these com-
plexes. In support of this conclusion, incubation with target
FIG. 4. Quantification of HN and Fwt protein complexes. The
amounts of HN and Fwt protein detected in complexes in four sepa-
rate experiments identical to those shown in Fig. 2 and 3 were aver-
aged, and the averages and standard deviations are shown. The neur-
aminidase treatments of HN and F protein-expressing cells as well
as target cells prior to lysis are shown at the bottom of the figure ( or
NA). No cells, no target cells added to HN and F protein expressing
cells. (A) Quantification of HN protein in the complexes as a percent-
age of the mature HN protein in each extract. (B) Quantification of
HN protein in complexes as a percentage of total HN protein in each
extract. (C) Quantification of F protein in the complexes as a percent-
age of the total F protein in each extract.
FIG. 5. Characterization of HN and F-K115Q protein complexes.
Cells were transfected with vector (lanes 1 to 3), cotransfected with
HN protein and F-K115Q protein cDNAs (lanes 4 to 7), or cotrans-
fected with HN protein and F-K115AQ-FLAG protein cDNAs (lanes
8 to 12). Immune complexes were formed using antibodies (Ab) indi-
cated at the top of panel A (IP Ab). IP, immunoprecipitation. (A) HN
protein in the complexes were detected using anti-AS (IB-HN). (B) F
protein present in the complexes was detected using anti-HR2 (lanes 1
to 7) or anti-FLAG monoclonal antibody (lanes 8 to 12) (IB F). IB,
immunoblot. Anti-Fmix, a mixture of anti-HR1, anti-HR2, anti-F2-96,
anti-Ftail, and anti-Fu1a. Anti-HNmAbs, a mixture of monoclonal
antibodies. T, total extracts, which represents 50% of that used for
immunoprecipitation. All proteins were electrophoresed in the pres-
ence of reducing agent.
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cells, either neuraminidase treated or untreated, did not sig-
nificantly change the amounts of the complexes detected. This
result cannot be due to a decrease in attachment activity of HN
protein in the presence of the uncleaved F protein. Attach-
ment, as measured by binding of red blood cells, was identical
in cells coexpressing HN and Fwt protein or F-K115Q protein
(data not shown). Thus, these results show that an uncleaved F
protein also complexed with HN protein. They further suggest
that disassociation of HN and F protein complexes required
not only HN protein attachment but also F protein cleavage.
DISCUSSION
While paramyxovirus F proteins are directly responsible for
membrane fusion, the viral attachment proteins are required
for fusion mediated by most F proteins. HN protein receptor
binding and the interactions between HN and F proteins are
thought to be central to activation of the fusion protein activ-
ity; however, the molecular mechanism involved is one of the
major unsolved problems in paramyxovirus entry. Initially it
was proposed that attachment of HN protein to sialic acid
receptors stimulates an interaction of HN protein with F pro-
tein, which leads to F protein activation, a model still favored
by some (3, 14). In contrast, Takimoto et al. (42), Zaitsev et al.
(50), and McGinnes et al. (23) have proposed that HN and F
proteins form a complex prior to attachment and that HN
protein receptor binding stimulates a conformational change
in the HN protein, which activates the F protein. Takimoto
et al. and Zaitsev et al. based their model on their analyses
of the structure of the NDV HN protein and the phenotype of
NDV HN mutants. These groups crystallized two forms of
the HN protein, one without bound ligand and one with
neu5Ac2en, an inhibitor that can be generated by the catalysis
of sialic acid from sialic acid-containing receptors (5, 50). They
have proposed that HN protein without bound ligand is in the
preattachment state, while HN protein with bound neu5Ac2en
represents the postattachment, catalytic form of the protein.
Comparisons of the two forms of HN protein showed that
there were significant differences in the positions of the resi-
dues in the catalytic site as well as loops that form the HN
protein dimer interface. Mutation of residues at the dimer
interface resulted in an HN protein that could bind to sialic
acid but that could not promote fusion (4, 42). These findings
led these groups to propose that conformational changes in
the HN protein dimer interface upon sialic acid binding
transmit a signal to an associated F protein which activates
its activity.
McGinnes et al. (23) also published evidence indicating that
NDV HN and F proteins form complexes prior to HN protein
receptor binding. A polyclonal antibody specific for the HR1
domain of the F protein bound to F protein on cell surfaces
only when F protein was coexpressed with HN protein. Fur-
thermore, the anti-HR1 antibody blocked the fusion of red
blood cells to the HN-F protein-expressing cells when bound
before HN protein engaged its receptors, but not after recep-
tor binding. These combined results suggested that the HR1
domain was accessible to anti-HR1 antibody binding only in
the presence of HN protein and only before engagement of
HN protein with receptors. These conclusions are consistent
with the idea that HN protein binds to the F protein prior to
HN protein receptor binding.
FIG. 6. Levels of attachment do not affect levels of HN and F-K115Q protein complexes. Cells cotransfected with HN and F-K115Q protein
cDNAs were untreated (NA, lanes 1 to 4) or incubated overnight in 0.5 U neuraminidase (NA, lanes 5 to 8). Immune complexes were formed
with antibodies (Ab) shown at the top (IP Ab). IP, immunoprecipitation. Alternatively, HN and F-K115Q cells were either untreated (lanes 9 to
12) or treated with neuraminidase overnight (lanes 13 to 20) and incubated with target cells that were either untreated (lanes 9 to 16) or treated
with neuraminidase for 1 h (lanes 17 to 20), washed, and then added on top of the HN and F protein-expressing cells. Incubation of target cells
with HN and F protein-expressing cells was for 1 h at 37°C. Immune complexes were formed with antibodies indicated at the top of panel A
(IP Ab). The HN protein in the complexes was detected using anti-AS (IB HN), and the F-K115Q protein was detected using anti-HR2 (IB F).
Anti-Fmix, a mixture of anti-HR1, anti-HR2, anti-F2-96, anti-Ftail, and anti-Fu1a. Anti-HNmAbs, a mixture of monoclonal antibodies. T, total cell
extract, which represents 50% of the amount used for immunoprecipitation. All proteins were electrophoresed in the presence of reducing agent.
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Results presented here provide more direct evidence in sup-
port of this proposal. If HN and F proteins form complexes
only after attachment, then inhibition of attachment by neur-
aminidase digestion of cell surfaces should result in a signifi-
cant decrease in these complexes. However, we have found
that removal of surface sialic acid significantly increased amounts
of HN and F protein-containing complexes. These results strongly
support the idea that complexes form in the absence of HN
protein attachment.
Finding increased amounts of HN and F protein complexes
after neuraminidase digestion of cell surfaces suggested that
HN protein receptor binding may cause disassociation of these
complexes. In support of this idea, we found that stimulation of
attachment and fusion by the addition of target cells to neur-
aminidase-treated HN and F protein-expressing cells resulted in a
significant decrease in detection of HN and F protein com-
plexes. This result is consistent with the idea that attachment is
associated with release of the F protein from the complex.
Yin et al. (47) have recently described the crystal structure
of the uncleaved, soluble form of the parainfluenza 3 F protein.
While the uncleaved molecule should be in a prefusion con-
formation, the HR1 and HR2 domains were complexed in this
structure, a conformation thought to be characteristic of the
postfusion conformation. While Yin et al. proposed that the
missing transmembrane and cytoplasmic domains of the solu-
ble F protein may be important for maintaining the prefusion
conformation, it is also possible the HN protein participates in
the maintenance of the prefusion conformation of the F pro-
tein and that most paramyxovirus F proteins are expressed in
a prefusion conformation only in the presence of the HN
protein. Our previous findings and those presented here are
consistent with this idea. That the HR1 domain is accessible to
antibody binding only when expressed with HN protein is con-
sistent with the idea that the HR1-HR2 complex forms in the
absence of HN protein masking the HR1 domain from anti-
body binding (23). We have previously reported that the F
protein HR2 domain can interact with a sequence in the HN
protein membrane-proximal region (8). Such an interaction
provides support for the idea that HN protein may prevent
HR1-HR2 complex formation by binding to the HR2 domain.
Furthermore, our results reported here, which indicate that
HN and F proteins form a complex prior to receptor binding,
are consistent with the idea that HN protein may facilitate the
prefusion conformation of the F protein. In addition, our re-
sults that show disassociation of these complexes upon HN
protein attachment and fusion are consistent with the idea that
this disassociation allows the formation of the HR1-HR2 com-
plex and, therefore, fusion.
Attachment of HN protein to receptors is not, however,
sufficient for disassociation of HN and F protein-containing
complexes. Amounts of complexes detected between HN and
the uncleaved F-K115Q protein were unaffected by neuramin-
idase treatment of cell monolayers, and the complexes did not
disassociate upon addition of target cells. It is possible that the
interactions of the uncleaved and cleaved F proteins with the
HN protein are different. Alternatively, additional conforma-
FIG. 7. Quantification of HN and F-K115Q protein complexes.
The amounts of HN and F-K115Q proteins detected in complexes in
three separate experiments identical to those shown in Fig. 6 were
averaged, and the averages and standard deviations are shown. The
treatments of HN and F protein-expressing cells, as well as target cells,
prior to lysis are shown at the bottom of the figure ( or NA). No
cells, no target cells added. (A) Quantification of HN protein in the
complexes as a percentage of the total mature HN protein in each
extract. (B) Quantification of F-K115Q protein in the complexes as a
percentage of the total F-K115Q protein in each extract.
FIG. 8. Potential model for HN and F protein associations. (A)
F-K115Q protein associates with both pre- and postattachment forms
of the HN protein. Perhaps the two forms are in equilibrium due to
HN protein neuraminidase. (B) Fwt protein associates with both forms
of the HN protein but can proceed with fusion and disassociation from
HN protein.
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tional changes in cleaved F protein or the actual fusion process
itself may result in dissociation of the two proteins.
Results presented here with the F-K115Q protein, coupled
with structural studies of the NDV HN protein (5, 50), suggest
that the uncleaved F protein may associate with both the pre-
attachment form and the postattachment form of HN protein
(Fig. 8A). The finding, described above for Fig. 1, that the
anti-F protein monoclonal antibody did not precipitate all the
HN and F protein complexes suggests that HN and Fwt protein
complexes may also exist in at least two forms (Fig. 8B). Some
additional conformational change possible only in the cleaved
F protein may be required for complex disassociation, as illus-
trated in Fig. 8B. Alternatively, the intermediate complex
(shown in Fig. 8B) containing a cleaved F protein may, with a
certain frequency, proceed to full fusion, which results in com-
plex disassociation.
Results reported here using transfected cells are consistent
with our previous results using infected cells (41). We have
previously shown that HN and F proteins on surfaces of in-
fected cells could be cross-linked and that this cross-linking
could occur after elimination of cell surface sialic acid with
neuraminidase. Furthermore, we saw an increase in cross-
linked complexes after neuraminidase treatment of infected
cells consistent with the increase, reported here, of HN and F
protein-containing complexes after neuraminidase digestion.
In our previous studies, we also added overlay cells to infected
cells, but we did not detect a decrease in levels of the HN and
F protein cross-linked complexes. In these experiments, how-
ever, the overlay cells were incubated with infected cells at 4°C.
Thus, it is likely that disassociation of the complexes did not
occur, because fusion did not proceed at the lower tempera-
ture. This result is consistent with our observations, reported
here, that attachment alone, which can occur at 4°C, is not
sufficient for disassociation of the HN and F protein-contain-
ing complexes.
Plemper et al. (35) have reported that complexes between
measles virus hemagglutinin and F proteins vary inversely with
the levels of fusion. This finding is very consistent with the
results presented here. Increased fusion should result in more
disassociation of HN and F protein complexes, while less fu-
sion would favor increased detection of complexes. Perhaps, as
suggested by Plemper et al., a tighter interaction between the
two proteins would decrease disassociation and, therefore, fu-
sion. It is also possible that any change that results in an F
protein with lowered fusion activity would, secondarily, de-
crease the disassociation of the complex.
Results reported here are also consistent with the report that
an attachment-defective HN protein can still complex with the
NDV F protein (18). On the other hand, Li et al. (18) and
Deng et al. (6) reported that other attachment-negative HN
protein mutants did not coimmunoprecipitate with F protein.
However, reciprocal coimmunoprecipitation with the mutant
protein was not demonstrated in these reports, and only one
anti-F protein monoclonal antibody was used to precipitate
HN protein. It is possible that some mutant HN proteins block
the binding site for this F protein antibody. Indeed, as noted
above, we have found that a single anti-F protein monoclonal
antibody did not precipitate all the HN protein in a complex
with F protein. If there are two forms of an HN-F protein
complex, as we have proposed in Fig. 8, then it is possible that
one form cannot be detected by a single monoclonal antibody.
Alternatively, these mutant HN proteins may have conforma-
tional abnormalities that result in defects in association with F
protein.
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